We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
And that would only value the mcap at arouund £2 billion. If designated as a breakthrough or just a boost for keytruder I think it will probably be a lot more. Considering Seres rose to over $2 billion for a hospital bug therapy. Cancer is a whole different level and everyone wants the cure rate for that improved worldwide. Lets keep our fingers crossed that they get the results. If they do I think that will be when the buyout offers start to come in.
Curing cancer is like an ongoing war with us humans and the fear of it is still engrained into our psyche, and also the fear of the treatment.
A SAFE thereapy would be phenomenal in all aspects
£10+ SP
Nightmarewalking
I don't agree at all: we are owed updates on mainstream projects that the company has told us that it embarked on and we were told the results were good enough to carry on and that commercial negotiations were already ongoing month ago (IBS) or they are projects / partnerships with multinational pharmas (antibodies), as simple as that. Furthermore, phase II covid-19 trial results were due last year.
You may want to note that one of the attractions of this company is that there are multiple projects iongoing so you can't claim arbitrarily that something ceases to be of strategic importance - please refer to the management presentations that are quite helpful. So I'm sure most of investors are looking forward to updates on the various fronts alongside the ones from MRx0518.
Phil, good news re Mrx0518 combination therapy is almost in the bag, because of the successful results so far. Nonetheless we are owed updates on what's next re phase II IBS (more than six months re last announcement), on covid phase II trial, on the vaccine and other programmes. It only partly accounts for weak price, I d think, but lack of updates re above isn't helping.
Very strange indeed, I've been asking myself the same question. Is there something I'm missing here, happy to hold.
Quiet period, gaps to be filled according to traders etc
Not a big deal, will turn at some point, possibly bottoming out lower than this though.
Don't understand this selling... someone is offloading I think, but why? We have catalysts coming up soon and company is looking good on several fronts imho. What are we missing here?
Right in the green bin for that garbage over the w/e. Bye.